Oaktree Acquisition Corp. III Life Sciences (OACC)

NASDAQ: OACC · Real-Time Price · USD
10.64
-0.06 (-0.53%)
Feb 27, 2026, 4:00 PM EST - Market closed
6.35%
Market Cap 261.44M
Revenue (ttm) n/a
Net Income (ttm) 2.66M
Shares Out 24.58M
EPS (ttm) n/a
PE Ratio 98.16
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 28
Open n/a
Previous Close 10.69
Day's Range n/a
52-Week Range 10.00 - 10.85
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About OACC

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Oct 24, 2024
Country United States
Stock Exchange NASDAQ
Ticker Symbol OACC
Full Company Profile

News

There is no news available yet.